Corbus Pharmaceuticals I... (CRBP)

AI Score

Unlock

4.93

-0.27 (-5.19%)

At close: Apr 03, 2025, 3:59 PM

5.05

2.39%

After-hours: Apr 03, 2025, 07:56 PM EDT

Corbus Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Revenue	n/a	n/a	n/a	881.71K	3.94M	36.14M	4.82M	2.44M	1.91M	648.38K	n/a	n/a	n/a
Cost of Revenue	n/a	31.17M	1.49M	1.64M	98.27K	89.6K	48.61M	26.04M	15.44M	5.89M	1.26M	n/a	n/a
Gross Profit	n/a	-31.17M	-1.49M	-757.53K	3.84M	36.05M	-43.79M	-23.6M	-13.53M	-5.24M	-1.26M	n/a	n/a
Operating Income	n/a	-45.08M	-39.84M	-55.99M	-122.81M	-77.1M	-56.75M	-32.56M	-19.99M	-8.85M	-2.65M	-557.28K	-824.15
Interest Income	6.31M	n/a	n/a	1.83K	1.03K	1.23M	982.78K	183.11K	477.00	3.42K	2.12K	754.00	59.74
Pretax Income	-40.21M	-44.6M	-42.35M	-45.64M	-111.27M	-71.45M	-55.67M	-32.42M	-20M	-8.85M	-2.54M	-602.35K	-886.96
Net Income	-40.21M	-44.6M	-55.83M	-45.55M	-111.3M	-69.15M	-55.67M	-32.42M	-20M	-8.85M	-2.54M	-602.35K	-886.96
Selling & General & Admin	16.5M	13.27M	18.7M	20.43M	28.48M	23.64M	12.96M	8.96M	6.46M	3.61M	1.39M	346.61K	289.05
Research & Development	32.22M	31.17M	16.14M	36.45M	98.27M	89.6M	48.61M	26.04M	15.44M	5.89M	1.26M	210.67K	575.09
Other Expenses	n/a	-30.53M	-48.77K	11.9M	13.27M	4.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	48.72M	13.91M	34.84M	56.87M	126.75M	113.25M	61.57M	35M	21.9M	9.5M	2.65M	557.28K	827.22
Interest Expense	-1.87M	2.92M	2.13M	1.83M	1.03M	19.02K	n/a	183.11K	n/a	2.44K	24.02K	45.11K	n/a
Selling & Marketing Expenses	n/a	-641K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	45.08M	34.84M	56.87M	126.75M	113.25M	61.57M	35M	21.9M	9.5M	2.65M	557.28K	827.22
Income Tax Expense	n/a	n/a	13.49M	-87.84K	35.05K	-2.3M	1.08M	-396.86K	13.62K	2.44K	24.02K	44.36K	-62.81
Shares Outstanding (Basic)	10.92M	4.33M	4.17M	4.1M	2.6M	2.13M	1.9M	1.67M	1.37M	1.05M	672K	860.06K	232.00
Shares Outstanding (Diluted)	10.92M	4.33M	4.17M	4.1M	2.6M	2.13M	1.9M	1.67M	1.37M	1.05M	672K	860.06K	232.16
EPS (Basic)	-3.68	-10.31	-13.39	-11.11	-42.74	-32.47	-29.3	-19.38	-14.58	-8.47	-3.78	-0.7	-3.82
EPS (Diluted)	-3.68	-10.31	-13.39	-11.11	-42.74	-32.47	-29.3	-19.38	-14.58	-8.47	-3.78	-0.7	-3.82
EBITDA	n/a	-44.44M	-38.73M	-54.97M	-121.69M	-76.37M	-56.25M	-32.31M	-19.9M	-8.81M	-2.64M	-556.52K	-62.81
EBIT	n/a	-45.08M	-40.21M	-55.99M	-122.81M	-77.1M	-56.75M	-32.56M	-19.99M	-8.85M	-2.65M	-557.28K	n/a
Depreciation & Amortization	n/a	641K	1.49M	1.64M	1.69M	1.23M	493.94K	255.65K	87.66K	43.94K	10.4K	754.00	824.15